Cargando…

Tau interactome and RNA binding proteins in neurodegenerative diseases

Pathological tau aggregation is a primary neuropathological feature of many neurodegenerative diseases. Intriguingly, despite the common presence of tau aggregates in these diseases the affected brain regions, clinical symptoms, and morphology, conformation, and isoform ratio present in tau aggregat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kavanagh, Tomas, Halder, Aditi, Drummond, Eleanor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575286/ https://www.ncbi.nlm.nih.gov/pubmed/36253823 http://dx.doi.org/10.1186/s13024-022-00572-6

Ejemplares similares

It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseases
por: Pires, Geoffrey, et al.
Publicado: (2021)

Strategies for translating proteomics discoveries into drug discovery for dementia
por: Halder, Aditi, et al.
Publicado: (2023)

Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases
por: Sadeghzadeh, Jafar, et al.
Publicado: (2023)

Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein–Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases
por: Li, Fengzhi, et al.
Publicado: (2022)

Tau imaging in neurodegenerative diseases
por: Dani, M., et al.
Publicado: (2015)

Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases
por: Kinoshita, Chisato, et al.
Publicado: (2021)

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
por: da Costa, Paulo J., et al.
Publicado: (2022)

Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues
por: Samudra, Niyatee, et al.
Publicado: (2023)

Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases
por: Mishan, Mohammad Amir, et al.
Publicado: (2019)

Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
por: Pires, Geoffrey, et al.
Publicado: (2019)

Calmodulin binding proteins and neuroinflammation in multiple neurodegenerative diseases
por: O’Day, Danton H., et al.
Publicado: (2022)

Acetylation changes tau interactome to degrade tau in Alzheimer’s disease animal and organoid models
por: Choi, Heesun, et al.
Publicado: (2019)

Validation and classification of RNA binding proteins identified by mRNA interactome capture
por: Vaishali,, et al.
Publicado: (2021)

RNA interactome capture in Escherichia coli globally identifies RNA-binding proteins
por: Stenum, Thomas Søndergaard, et al.
Publicado: (2023)

The Importance of Tau Phosphorylation for Neurodegenerative Diseases
por: Noble, Wendy, et al.
Publicado: (2013)

Compilation of reported protein changes in the brain in Alzheimer’s disease
por: Askenazi, Manor, et al.
Publicado: (2023)

Discovery of RNA-binding proteins and characterization of their dynamic responses by enhanced RNA interactome capture
por: Perez-Perri, Joel I., et al.
Publicado: (2018)

RNA-dependent interactome allows network-based assignment of RNA-binding protein function
por: Fradera-Sola, Albert, et al.
Publicado: (2023)

Comprehensive Identification of mRNA-Binding Proteins of Leishmania donovani by Interactome Capture
por: Nandan, Devki, et al.
Publicado: (2017)

Tau protein- induced sequestration of the eukaryotic ribosome: Implications in neurodegenerative disease
por: Banerjee, Senjuti, et al.
Publicado: (2020)

Dysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders
por: Maziuk, Brandon, et al.
Publicado: (2017)

Aggregate Interactome Based on Protein Cross-linking Interfaces Predicts Drug Targets to Limit Aggregation in Neurodegenerative Diseases
por: Balasubramaniam, Meenakshisundaram, et al.
Publicado: (2019)

The transcription factor X-box binding protein-1 in neurodegenerative diseases
por: Dunys, Julie, et al.
Publicado: (2014)

Large-scale map of RNA binding protein interactomes across the mRNA life-cycle
por: Street, Lena, et al.
Publicado: (2023)

The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
por: Wolfe, Michael S.
Publicado: (2012)

Tau mis-splicing in the pathogenesis of neurodegenerative disorders
por: Park, Sun Ah, et al.
Publicado: (2016)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core
por: Vacchi, Elena, et al.
Publicado: (2020)

Illuminating the dark protein-protein interactome
por: Sharifi Tabar, Mehdi, et al.
Publicado: (2022)

The multi‐functional RNA‐binding protein G3BP1 and its potential implication in neurodegenerative disease
por: Sidibé, Hadjara, et al.
Publicado: (2021)

The transcript interactome of skeletal muscle RNA binding protein motif 3 (RBM3)
por: Hettinger, Zachary R., et al.
Publicado: (2023)

Protein-mRNA interactome capture: cartography of the mRNP landscape
por: Ryder, Sean P.
Publicado: (2016)

Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
por: Tracy, Tara E., et al.
Publicado: (2022)

Translation factor and RNA binding protein mRNA interactomes support broader RNA regulons for posttranscriptional control
por: Kershaw, Christopher J., et al.
Publicado: (2023)

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
por: Diez, Lisa, et al.
Publicado: (2020)

Dissecting noncoding and pathogen RNA–protein interactomes
por: Flynn, Ryan A., et al.
Publicado: (2015)

The Interactome of the VAP Family of Proteins: An Overview
por: James, Christina, et al.
Publicado: (2021)

Correction to The transcript interactome of skeletal muscle RNA binding protein motif 3 (RBM3)
Publicado: (2023)

RNA interactomics: recent advances and remaining challenges
por: Schönberger, Brigitte, et al.
Publicado: (2018)

Tau PET imaging in neurodegenerative tauopathies—still a challenge
por: Leuzy, Antoine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v9netfilimj70ch9m7nep94ebq